Dagogo-Jack S, Cannon CP, Cherney DZI, Cosentino F, et al. Cardiorenal outcomes with ertugliflozin assessed according to baseline glucose-lowering agent: An analysis from VERTIS CV. Diabetes Obes Metab 2022;24:1245-1254.
PMID: 35266296